Polygenic risk scores for atrial fibrillation and heart failure and the risk of stroke and dementia

Atrial fibrillation and heart failure have both been suggested to increase stroke and dementia risk. However, in observational studies, reversed causation and unmeasured confounding may occur. To mitigate these issues, this study aims to investigate if higher genetic risk for atrial fibrillation and heart failure increases dementia and stroke risk. Data were obtained from the population-based Gothenburg H70 Birth Cohort Studies in Sweden. Participants (<i>N</i> = 984) were born in 1930 with baseline examinations at age 70, 75, 79 or 85 and follow-ups until age 88-89. Polygenic risk scores at the 5 × 10<sup>-8</sup>, 1 × 10<sup>-5</sup>, 1 × 10<sup>-3</sup> and 1 × 10<sup>-1</sup> thresholds were generated for atrial fibrillation and heart failure. Stroke was diagnosed based on self-reports, close-informant interviews, and the National Patient Register. Dementia was diagnosed based on neuropsychiatric examinations, close-informant interviews, and the National Patient Register. Cox regression analyses were performed, adjusted for sex, age at baseline and the first five principal components to correct for population stratification. Those within the highest atrial fibrillation-polygenic risk score tertile had a 1.5 (95% CI 1.09-2.03) increased risk of dementia (at the 1 × 10<sup>-5</sup> threshold) and a 1.5 (95% CI 1.07-2.03) increased risk of stroke (at the 1 × 10<sup>-3</sup> threshold) compared to the lowest tertile. Those within the highest heart failure-polygenic risk score tertile had a 1.6 (95% CI 1.19-2.27) increased risk of dementia (at the 5 × 10<sup>-8</sup> threshold), but no increased risk of stroke (HR 1.2; 95% CI 0.83-1.60 at the 1 × 10<sup>-5</sup> threshold), compared to the lowest tertile. When analysing the polygenic risk scores as a continuous variable, the associations were in the same direction, although weaker. This study, investigating genetic risk of atrial fibrillation and heart failure in relation to stroke and dementia, supports the increasing body of evidence suggesting that atrial fibrillation is associated with both stroke and dementia risk. Whether heart failure increases dementia risk is less established, but the present study found that genetic risk of heart failure increased dementia risk. The finding that genetic risk for heart failure did not increase stroke risk needs to be interpreted with caution, as it may be due to a lack of statistical power. There are guidelines on how to best treat atrial fibrillation to prevent stroke, but more knowledge is needed on how to treat atrial fibrillation and heart failure to prevent dementia.

Authors

Institutions

Publication Details

Journal
Brain Communications
Published
2024-12-24
DOI
https://doi.org/10.1093/braincomms/fcae477
Citations
1
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.40

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Polygenic risk scores for atrial fibrillation and heart failure and the risk of stroke and dementia

Nazib M. Seidu, Margda Wærn, Hanna Wetterberg, Ingmar Gr. Skoog et al.
1 citations
Brain Communications
Atrial Fibrillation Management and Outcomes
0.40
article

Polygenic risk scores for atrial fibrillation and heart failure and the risk of stroke and dementia

Nazib M. Seidu, Margda Wærn, Hanna Wetterberg, Ingmar Gr. Skoog, Jenna Najar, Anna Zettergren, Silke Kern, Henrik Zetterberg, Lina Rydén, Kaj Blennow
article en
1 citations

Abstract

Atrial fibrillation and heart failure have both been suggested to increase stroke and dementia risk. However, in observational studies, reversed causation and unmeasured confounding may occur. To mitigate these issues, this study aims to investigate if higher genetic risk for atrial fibrillation and heart failure increases dementia and stroke risk. Data were obtained from the population-based Gothenburg H70 Birth Cohort Studies in Sweden. Participants (<i>N</i> = 984) were born in 1930 with baseline examinations at age 70, 75, 79 or 85 and follow-ups until age 88-89. Polygenic risk scores at the 5 × 10<sup>-8</sup>, 1 × 10<sup>-5</sup>, 1 × 10<sup>-3</sup> and 1 × 10<sup>-1</sup> thresholds were generated for atrial fibrillation and heart failure. Stroke was diagnosed based on self-reports, close-informant interviews, and the National Patient Register. Dementia was diagnosed based on neuropsychiatric examinations, close-informant interviews, and the National Patient Register. Cox regression analyses were performed, adjusted for sex, age at baseline and the first five principal components to correct for population stratification. Those within the highest atrial fibrillation-polygenic risk score tertile had a 1.5 (95% CI 1.09-2.03) increased risk of dementia (at the 1 × 10<sup>-5</sup> threshold) and a 1.5 (95% CI 1.07-2.03) increased risk of stroke (at the 1 × 10<sup>-3</sup> threshold) compared to the lowest tertile. Those within the highest heart failure-polygenic risk score tertile had a 1.6 (95% CI 1.19-2.27) increased risk of dementia (at the 5 × 10<sup>-8</sup> threshold), but no increased risk of stroke (HR 1.2; 95% CI 0.83-1.60 at the 1 × 10<sup>-5</sup> threshold), compared to the lowest tertile. When analysing the polygenic risk scores as a continuous variable, the associations were in the same direction, although weaker. This study, investigating genetic risk of atrial fibrillation and heart failure in relation to stroke and dementia, supports the increasing body of evidence suggesting that atrial fibrillation is associated with both stroke and dementia risk. Whether heart failure increases dementia risk is less established, but the present study found that genetic risk of heart failure increased dementia risk. The finding that genetic risk for heart failure did not increase stroke risk needs to be interpreted with caution, as it may be due to a lack of statistical power. There are guidelines on how to best treat atrial fibrillation to prevent stroke, but more knowledge is needed on how to treat atrial fibrillation and heart failure to prevent dementia.

Brain CommunicationsVol. 7(1)
University of Science and Technology of China (CN), University of Wisconsin–Madison (US), Lund University (SE), Hong Kong University of Science and Technology (HK), Sahlgrenska University Hospital (SE), Sorbonne Université (FR), Region Västra Götaland (SE), Amsterdam Neuroscience (NL), Pitié-Salpêtrière Hospital (FR), UK Dementia Research Institute (GB), Amsterdam University Medical Centers (NL), Institut du Cerveau (FR), University College London (GB), Vrije Universiteit Amsterdam (NL), University of Gothenburg (SE)
Alzheimer's Association, Alzheimer's Drug Discovery Foundation, Familjen Erling-Perssons Stiftelse, Cure Alzheimer's Fund, Stiftelsen för Gamla Tjänarinnor, EU Joint Programme – Neurodegenerative Disease Research, National Institute for Health and Care Research, University College London, European Commission, Stiftelsen Handlanden Hjalmar Svenssons, Stiftelserna Wilhelm och Martina Lundgrens, Hjärnfonden, Vetenskapsrådet, Forskningsrådet om Hälsa, Arbetsliv och Välfärd, Kirsten og Freddy Johansens Fond, Stiftelsen Psykiatriska Forskningsfonden, UK Dementia Research Institute, Demensfonden, Olav Thon Stiftelsen, Fondation pour la Recherche sur Alzheimer, HORIZON EUROPE Framework Programme, UCLH Biomedical Research Centre
Good health and well-being
Openalex Percentile: Top 29%
Atrial Fibrillation Management and Outcomes
0.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.